Get the Stockscreener App
112.11
0.37%
0.41
After Hours:
112.11
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $112.11, with a volume of 1.68M.
It is up +0.37% in the last 24 hours and down -8.01% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$111.70
Open:
$111.94
24h Volume:
1.68M
Relative Volume:
0.76
Market Cap:
$31.68B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
24.72
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
+0.58%
1M Performance:
-8.01%
6M Performance:
-22.06%
1Y Performance:
-1.46%
1-Day Range:
$110.81
$113.59
1-Week Range:
$110.81
$115.66
52-Week Range:
$107.07
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
112.11 | 31.57B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
442.00 | 162.90B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
163.86 | 114.60B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
545.79 | 41.71B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
332.19 | 32.32B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Technologies’ SWOT analysis: stock gains momentum on market recovery - Investing.com
Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading - Yahoo Finance Singapore
Agilent Technologies Inc. stock (US00846U1016): earnings miss and cautious outlook keep sentiment su - AD HOC NEWS
TRADE NEWS: Agilent Technologies Introduces Industry's First LTE-Advanced 8x8 MIMO Signal-Generation - AOL.com
Agilent Tech Q2 Net Drops, Job Cuts and Share Repurchase Widening Announced - AOL.com
Agilent Deepens India Biologics Ties While Targeting High Speed Debugging - Yahoo Finance
What makes Agilent (A) a new buy stock - MSN
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
AAgilent Technologies Inc Stock Price and Quote - Finviz
Agilent $40M Expansion Doubles Chicopee Manufacturing Site - Hoodline
Agilent Technologies opens new Chicopee manufacturing facility - The Reminder
Agilent invests $40M to double Massachusetts manufacturing site - The Business Journals
What Makes Agilent (A) a New Buy Stock - Yahoo Finance
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a cent as guidance points t - AD HOC NEWS
Agilent Technologies (A) Stock Forecast and Price Target 2026 $A - MarketBeat
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a hair while revenue rises - AD HOC NEWS
Global company Agilent Technologies opens new Chicopee site - WWLP
TRADE NEWS: Agilent Technologies Introduces New Portable Logic Analyzers - AOL.com
Agilent Technologies stock (US00846U1016): Recent patent ruling and market updates - AD HOC NEWS
Agilent & Veeda Lifesciences Strengthen Biopharma Analytics with New Facility - Digital Health News
Agilent Technologies (A) Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story - Sahm
Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp. - marketscreener.com
Agilent and Veeda Lifesciences open joint analytical Centre of Excellence in Bengaluru - BioSpectrum India
Agilent Technologies Inc. stock (US00846U1016): Short interest rises amid market pressures - AD HOC NEWS
Agilent And Veeda Lifesciences Launch Joint Analytical Center Of Excellence To Accelerate GLP‑1 And Complex Biologics Development Services. - TRIPURA STAR NEWS
Agilent and Veeda Lifesciences Launch Joint Analytical CoE to Accelerate GLP‑1 and Complex Biologics Development Services - Indianweb2.com
Agilent Technologies or Danaher: Which Stock Has More Upside? - Trefis
Agilent Technologies to Present at Jefferies Healthcare Conference on June 4, 2026, at 9:00 AM ET - geneonline.com
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent (A) SVP Simon May surrenders 368 shares to cover RSU tax bill - Stock Titan
Here's what to expect from Agilent Technologies’ next earnings report - MSN
C-CAMP announces expansion of tie-up with Agilent - The Hindu
Agilent and C‑CAMP Expand Collaboration to Boost India’s Biopharma Research Infrastructure - Indianweb2.com
Agilent expands collaboration with C-CAMP to scale access to advanced life sciences analytics - BioSpectrum India
Agilent to Participate in Jefferies Global Healthcare Conference 2026 - BioSpace
Agilent to Participate in Jefferies Global Healthcare Conference - The National Law Review
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent Technologies stock (US00846U1016): Q1 earnings miss and upcoming Q2 report - AD HOC NEWS
Agilent Technologies stock (US00846U1016): Q1 earnings miss and updated guidance - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors - DirectorsTalk Interviews
Crossmark Global Holdings Inc. Acquires 9,615 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo Finance
Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals? - simplywall.st
FDA approves Agilent PD-L1 test for esophageal cancer - SelectScience
Agilent Technologies Inc. stock (US00846U1016): FDA approval and earnings miss shape outlook - AD HOC NEWS
Generali Asset Management SPA SGR Has $7.38 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
TRADE NEWS: Agilent Technologies' Model Extraction and Qualification Software Adopted by Shanghai Co - Yahoo
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
[Form 3] AGILENT TECHNOLOGIES, INC. Initial Statement of Beneficial Ownership - Stock Titan
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows - Manufacturing Chemist
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):